LONDON (AP) — GlaxoSmithKline PLC reported Wednesday a 13 percent drop in first-quarter net profit compared with a year earlier, when earnings were heavily boosted by the sale of a unit.
GlaxoSmithKline shares were down 2.4 percent at 1,422 pence as its results were weaker than anticipated.
The pharmaceutical company said profit after tax was 1.325 billion pounds ($2.1 billion), down from 1.525 billion pounds a year earlier. Profit in the first quarter of 2011 was boosted by the 1.2 billion-pound sale of the company's stake in Quest, a U.S. medical lab operator, and its North American interests in Zovirax cold sore cream.
The profit decline came despite a near 1 percent rise in revenues to 6.64 billion pounds.
James Dawson, analyst at Charles Stanley & Co, said there wasn't "any significant catalyst at this point for investors to invest further in GSK."
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.